| Nicole Gerami, SLP | |
|
23275 Commerce Park #105, Beachwood, OH 44122 | |
| (216) 292-7370 | |
| (216) 292-7042 |
| Full Name | Nicole Gerami |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 23275 Commerce Park #105, Beachwood, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104968106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP4917 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Gerami, SLP 23275 Commerce Park Rd., Suite 105, Beachwood, OH 44122 Ph: (216) 292-7370 | Nicole Gerami, SLP 23275 Commerce Park #105, Beachwood, OH 44122 Ph: (216) 292-7370 |
News Archive
Clinical drug trials are a vital part of pharmaceutical manufacturers gaining approval for use by the U.S. Food and Drug Administration. A Commentary scheduled for publication in The Journal of Pediatrics assesses the issues surrounding the lack of clinical trials on medications used by children, most notably neonates, and how drug manufacturers and academic researchers could work together to create clinical trials that would benefit this underrepresented population.
Despite high hopes and high investment in CRISPR-Cas9 gene editing, scientists still have a lot to learn about how it works in humans.
Scientists have developed a new drug (RPL554) that could treat obstructive airway diseases such as asthma and chronic obstructive pulmonary disease in two ways at once, according to new research published in The Lancet Respiratory Medicine.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.
The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer. Results will provide researchers with a data needed to guide a phase 3 trial.
› Verified 4 days ago
Allison Fifolt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 23775 Greenlawn Ave, Beachwood, OH 44122 Phone: 216-223-8761 | |
Mrs. Jessica Steffes Maicki, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 23825 Commerce Park, Ste. B, Beachwood, OH 44122 Phone: 216-292-7370 Fax: 216-292-7042 | |
Anat Nurko, MA.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26505 Hendon Rd, Beachwood, OH 44122 Phone: 216-789-8987 | |
Ms. Esther Ann-louise Verbovszky, M.A. CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3700 Park East Dr Ste 100, Beachwood, OH 44122 Phone: 216-320-2456 | |
Ms. Robin F Douglass, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25077 Maidstone Ln, Beachwood, OH 44122 Phone: 216-374-5154 | |
Amy Eterovich, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2000 Auburn Dr Ste 200, Beachwood, OH 44122 Phone: 877-407-3422 Fax: 877-407-4329 | |
Lauren Kathleen Coster, M.A. SLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3628 Walnut Hills Ave, Beachwood, OH 44122 Phone: 440-580-0088 |